{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:19:12Z","timestamp":1788923952630,"version":"build-2803163510"},"reference-count":43,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004828","name":"Grand Challenges Canada","doi-asserted-by":"publisher","award":["R-ST-POC-1707\\u201307275"],"award-info":[{"award-number":["R-ST-POC-1707\\u201307275"]}],"id":[{"id":"10.13039\/501100004828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jmsacl.2024.10.001","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T20:32:50Z","timestamp":1728592370000},"page":"8-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Liquid chromatography-mass spectrometric method for the simultaneous analysis of branched-chain amino acids and their ketoacids from dried blood spot as secondary analytes for the detection of maple syrup urine disease"],"prefix":"10.21627","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-0995","authenticated-orcid":false,"given":"Arya","family":"Raveendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-6821","authenticated-orcid":false,"given":"Leslie E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-9597","authenticated-orcid":false,"given":"Krishnananda","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-0981","authenticated-orcid":false,"given":"Sudheer","family":"Moorkoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"10","key":"10.1016\/j.jmsacl.2024.10.001_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/TACG.S125962","article-title":"Maple syrup urine disease: mechanisms and management","volume":"6","author":"Blackburn","year":"2017","journal-title":"Application of Clinical Genetics."},{"key":"10.1016\/j.jmsacl.2024.10.001_b0010","unstructured":"K.A. Strauss, E.G. Puffenberger, V.J. Carson, Maple Syrup Urine Disease. In: M.P. Adam, J. Feldman, G.M. Mirzaa, R.A. Pagon, S.E. Wallace, L.J. Bean, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2023 Nov 27]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1319\/."},{"issue":"15","key":"10.1016\/j.jmsacl.2024.10.001_b0015","first-page":"106","article-title":"Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data","volume":"1","author":"Chapman","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21101\/cejph.a5441","article-title":"Epidemiology of rare diseases detected by newborn screening in the Czech Republic","volume":"27","author":"David","year":"2019","journal-title":"Cent. Eur. J. Public Health"},{"issue":"16","key":"10.1016\/j.jmsacl.2024.10.001_b0025","first-page":"5","article-title":"Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening","volume":"1","author":"Shibata","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.10.001_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40104-016-0139-z","article-title":"Novel metabolic and physiological functions of branched chain amino acids: a review","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Animal Sci. Biotechnol."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.10.001_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5717\/jenb.2013.17.4.169","article-title":"Effect of BCAA intake during endurance exercises on fatigue substances, muscle damage substances, and energy metabolism substances","volume":"17","author":"Kim","year":"2013","journal-title":"J. Exerc. Nutrition Biochem."},{"issue":"6","key":"10.1016\/j.jmsacl.2024.10.001_b0040","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11064-017-2261-5","article-title":"Branched-chain amino acids and brain metabolism","volume":"42","author":"Sperringer","year":"2017","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.10.001_b0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","article-title":"Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles","volume":"41","author":"Barschak","year":"2008","journal-title":"Clin. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2024.10.001_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00207459408986065","article-title":"Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity","volume":"79","author":"Korein","year":"1994","journal-title":"Int. J. Neurosci."},{"issue":"157","key":"10.1016\/j.jmsacl.2024.10.001_b0055","article-title":"Pathophysiology of maple syrup urine disease: focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain \u03b1-keto acids","volume":"1","author":"Amaral","year":"2022","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.10.001_b0060","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.3390\/ijms23074022","article-title":"The critical role of the branched chain amino acids (BCAAs) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and branched-chain \u03b1-keto acid dehydrogenase (BCKD), in human pathophysiology","volume":"23","author":"Dimou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.jmsacl.2024.10.001_b0065","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1373\/clinchem.2008.105270","article-title":"Maple syrup urine disease: newborn screening fails to discriminate between classic and variant forms","volume":"54","author":"Fingerhut","year":"2008","journal-title":"Clin. Chem."},{"issue":"548","key":"10.1016\/j.jmsacl.2024.10.001_b0070","article-title":"Newborn screening of maple syrup urine disease and the effect of early diagnosis","volume":"1","author":"Chen","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.jmsacl.2024.10.001_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jhrc.1240200703","article-title":"Analytical approach in diagnosis of inherited metabolic diseases: Maple syrup urine disease (MSUD) \u2013 simultaneous analysis of metabolites in urine by enantioselective multidimensional capillary gas chromatography-mass spectrometry (enantio-MDGC-MS)","volume":"20","author":"Podebrad","year":"1997","journal-title":"J. High Resolut. Chromatogr."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.10.001_b0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2004.11.010","article-title":"Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification","volume":"84","author":"Heldt","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.jmsacl.2024.10.001_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/clinchem\/41.1.62","article-title":"Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry","volume":"41","author":"Chace","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jmsacl.2024.10.001_b0090","unstructured":"EMA. European Medicines Agency. 2019 [cited 2023 Jul 22]. ICH M10 on bioanalytical method validation - Scientific guideline. Available from: https:\/\/www.ema.europa.eu\/en\/ich-m10-bioanalytical-method-validation-scientific-guideline."},{"key":"10.1016\/j.jmsacl.2024.10.001_b0095","unstructured":"Bioanalytical Method Validation Guidance for Industry | FDA [Internet]. [cited 2024 Mar 26]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry."},{"issue":"18","key":"10.1016\/j.jmsacl.2024.10.001_b0100","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.4155\/bio.14.185","article-title":"Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review","volume":"6","author":"Jager","year":"2014","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC\u2013MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0110","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1542\/peds.2008-2654","article-title":"Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system","volume":"123","author":"Jopling","year":"2009","journal-title":"Pediatrics"},{"issue":"16","key":"10.1016\/j.jmsacl.2024.10.001_b0115","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4155\/bio-2021-0130","article-title":"Validation of an HPLC method for estimation of cefotaxime from dried blood spot: alternative to plasma-based PK evaluation in neonates","volume":"13","author":"Chaudhari","year":"2021","journal-title":"Bioanalysis"},{"issue":"4","key":"10.1016\/j.jmsacl.2024.10.001_b0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jmsacl.2024.10.001_b0125","unstructured":"H.H. Billett, Hemoglobin and Hematocrit. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations [Internet]. 3rd ed. Boston: Butterworths; 1990 [cited 2024 Aug 29]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK259\/."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.10.001_b0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.14.298","article-title":"What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?","volume":"7","author":"Koster","year":"2015","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4155\/bio-2019-0201","article-title":"Effect of blood volume on analytical bias in dried blood spots prepared for newborn screening external quality assurance","volume":"12","author":"Moat","year":"2020","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.jmsacl.2024.10.001_b0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1373\/clinchem.2015.247668","article-title":"Effect of dried blood spot quality on newborn screening analyte concentrations and recommendations for minimum acceptance criteria for sample analysis","volume":"62","author":"George","year":"2016","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.jmsacl.2024.10.001_b0145","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jmsacl.2024.10.001_b0150","first-page":"565","article-title":"Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and \u03b1-keto acids in plasma and dried blood samples using HPLC with fluorescence detection","volume":"47","author":"Kand\u2019\u00e1r","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.10.001_b0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1373\/clinchem.2007.098434","article-title":"Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)","volume":"54","author":"Oglesbee","year":"2008","journal-title":"Clin. Chem."},{"issue":"1063","key":"10.1016\/j.jmsacl.2024.10.001_b0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2017.08.011","article-title":"Simultaneous measurement of whole blood vitamin B1 and vitamin B6 using LC-ESI\u2013MS\/MS","volume":"15","author":"Roelofsen-de Beer","year":"2017","journal-title":"J. Chromatogr. B"},{"issue":"1198","key":"10.1016\/j.jmsacl.2024.10.001_b0165","article-title":"Analyte recovery in LC-MS\/MS bioanalysis: an old issue revisited","volume":"15","author":"Kumar","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"126","key":"10.1016\/j.jmsacl.2024.10.001_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpba.2016.03.052","article-title":"Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry","volume":"15","author":"Kadian","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"132","key":"10.1016\/j.jmsacl.2024.10.001_b0175","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jbusres.2021.03.066","article-title":"So many ways for assessing outliers: What really works and does it matter?","volume":"1","author":"Sullivan","year":"2021","journal-title":"J. Bus. Res."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.10.001_b0180","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1515\/CCLM.2004.133","article-title":"Diagnostic and epidemiological implications of regional differences in serum concentrations of proteins observed in six Asian cities","volume":"42","author":"Ichihara","year":"2004","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1373\/clinchem.2007.091843","article-title":"Sources of variation of commonly measured serum analytes in 6 asian cities and consideration of common reference intervals","volume":"54","author":"Ichihara","year":"2008","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.jmsacl.2024.10.001_b0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12291-023-01128-1","article-title":"Establishment of age specific reference interval for aminoacids and acylcarnitine in dried blood spot by tandem mass spectrometry","volume":"39","author":"Kumar","year":"2024","journal-title":"Ind J Clin Biochem."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.10.001_b0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.10.001_b0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: Principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.jmsacl.2024.10.001_b0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.jmsacl.2024.10.001_b0210","first-page":"46","article-title":"Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features","volume":"1","author":"Chiong","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.jmsacl.2024.10.001_b0215","doi-asserted-by":"crossref","unstructured":"A. MacDonald, Principles of Dietary Management. In: G.F. Hoffmann, J. Zschocke, W.L. Nyhan, editors. Inherited Metabolic Diseases: A Clinical Approach [Internet]. Berlin, Heidelberg: Springer; 2017 [cited 2023 Nov 28]. p. 139\u201353. Available from: https:\/\/doi.org\/10.1007\/978-3-662-49410-3_21.","DOI":"10.1007\/978-3-662-49410-3_21"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X24000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:48Z","timestamp":1767770568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X24000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":43,"alternative-id":["S2667145X24000324"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.10.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid chromatography-mass spectrometric method for the simultaneous analysis of branched-chain amino acids and their ketoacids from dried blood spot as secondary analytes for the detection of maple syrup urine disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}